Incidence and predictors of anthracycline-related left ventricular dysfunction in acute myeloid leukemia-Reference-Cited by-同舟云学术

Incidence and predictors of anthracycline-related left ventricular dysfunction in acute myeloid leukemia

Published:2023-09 Issue: Volume:132 Page:107351
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Stahl Maximilian,Giblin Gerard^ORCID,Liu Yiwen,Winer Eric S.^ORCID,Garcia Jacqueline S.,Chen Evan^ORCID,Wadleigh Martha,Ling Kelly,Lindsley R. Coleman,Shimony Shai^ORCID,Copson Kevin,Charles Anne,DeAngelo Daniel J.,Stone Richard M.,Nohria Anju,Luskin Marlise R.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference32 articles.

1. Cytosine arabinoside (NSC-63878) and daunorubicin (NSC-83142) therapy in acute nonlymphocytic leukemia;Yates;Cancer Chemother. Rep.,1973

2. CPX-351 (cytarabine and daunorubicin) liposome for injection versus conventional cytarabine plus daunorubicin in older patients with newly diagnosed secondary acute myeloid leukemia;Lancet;J. Clin. Oncol.,2018

3. Anthracycline-related cardiotoxicity in older patients with acute myeloid leukemia: a Young SIOG review paper;Neuendorff;Blood Adv.,2020

4. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC committee for practice guidelines: The task force for cancer treatments and cardiovascular toxicity of the European society of cardiology (ESC);Zamorano;Eur. J. Heart Fail.,2017

5. Risk factors for anthracycline-induced cardiotoxicity;Qiu;Front. Cardiovasc. Med.,2021

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytarabine;Reactions Weekly;2023-10-07